ALX Oncology Reports Positive Interim Phase 2 Data From ASPEN-06 Trial Of Evorpacept For Cancer

RTTNews | 1134 hari yang lalu
ALX Oncology Reports Positive Interim Phase 2 Data From ASPEN-06 Trial Of Evorpacept For Cancer

(RTTNews) - Immuno-oncology company ALX Oncology Holdings Inc. (ALXO) announced Tuesday positive prespecified interim Phase 2 data from its ASPEN-06 clinical trial, a randomized multi-center international study evaluating evorpacept, the Company's CD47 blocking therapeutic, in combination with trastuzumab, CYRAMZA (ramucirumab) and paclitaxel for the treatment of patients with HER2-positive gastric/gastroesophageal junction (GEJ) cancer.

Evorpacept is the first CD47 blocker to show activity in a global randomized study in solid tumors.

The interim efficacy results showed the confirmed overall response rate for evorpacept combination treatment was 52% compared to 22% for control treatment.

This prespecified interim analysis represents results from 54 randomized patients with second and third line gastric/GEJ cancer, including a meaningful number of patients previously treated with ENHERTU (trastuzumab deruxtecan) and checkpoint inhibitors.

Patients were treated with evorpacept at 30 mg/kg every two weeks, mirroring the treatment cycle of trastuzumab, CYRAMZA and paclitaxel.

baca selengkapnya
U.S. Dollar Advances Amid Rising Fed Rate Hike Expectations Following CPI Release

U.S. Dollar Advances Amid Rising Fed Rate Hike Expectations Following CPI Release

The U.S. Dollar value moved higher on Tuesday with heightening expectations of an interest rate hike by the U.S. Federal Reserve following the release of U.S. inflation data which came in exceeding analysts' forecasts. In addition, despite a pause in the U.S. attacks on Iran, the absence of a breakthrough in negotiations kept inflation concerns alive.
RTTNews | 1 jam 20 menit yang lalu
European Markets Finished Mixed On Tuesday

European Markets Finished Mixed On Tuesday

The major European markets finished mostly higher on Tuesday, although they trended downward throughout the day and ended on opposite sides of the unchanged line.
RTTNews | 5 jam 6 menit yang lalu
FTSE 100 Firm Above The Flatline

FTSE 100 Firm Above The Flatline

The FTSE 100 benchmark of the London Stock Exchange is trading firmly above the flatline even as global market sentiment suffered following disappointing inflation data from the U.S. The hawkish comments from a Fed official further renewed rate hike expectations, dampening overall market sentiment.
RTTNews | 8 jam 26 menit yang lalu
U.S. Consumer Prices Climb 0.4% In October, More Than Expected

U.S. Consumer Prices Climb 0.4% In October, More Than Expected

Consumer prices in the U.S. increased by more than expected in the month of October, according to a closely watched report released by the Labor Department on Tuesday. The Labor Department said its consumer price index rose by 0.4 percent in October after climbing by 0.6 percent in September. Economists had expected consumer prices to rise by 0.3 percent.
RTTNews | 8 jam 37 menit yang lalu
CAC 40 Extends Gains

CAC 40 Extends Gains

The CAC 40 index that tracks the 40 largest French stocks based on the Euronext Paris added to Monday's gains as markets cheered the global rebound in tech shares.
RTTNews | 9 jam 15 menit yang lalu
DAX Rises Further On Tuesday

DAX Rises Further On Tuesday

The DAX benchmark that tracks the performance of the 40 largest companies listed on the Frankfurt Stock Exchange rallied further on Tuesday amidst a global rebound in technology shares and a continued decline in crude oil prices.
RTTNews | 10 jam 2 menit yang lalu